Topic: Excessive pricing

Mexico hits drug distributors with highest possible fine

Mexico’s competition enforcer has fined five drug distributors, an industry association and 21 executives the highest possible combined sanction of €38.5 million, while also disqualifying senior company employees for the first time in its history.

17 August 2021

CMA to probe “exploitative” coronavirus testing kit prices

The UK’s antitrust watchdog has agreed to advise the government on whether travellers are being charged excessive prices for covid-19 tests after the health secretary asked it to conduct a “rapid high-level review”.

09 August 2021

CMA reaccuses Pfizer and Flynn of excessive pricing

The UK’s Competition and Markets Authority has accused Pfizer and Flynn Pharma of charging unfairly high prices for an anti-epilepsy medication, 17 months after an appellate court ordered the agency to redo parts of its initial probe into the drugmakers.

05 August 2021

CMA doles out £100 million in fines for excessive pricing of thyroid drug

The UK’s Competition and Markets Authority has hit Advanz Pharma and its two former owners with more than £100 million in fines for overcharging the country’s national health service for thyroid medication liothyronine over an eight-year period.

29 July 2021

Dutch enforcer issues first excessive pricing fine

The Dutch competition authority has fined Leadiant Biosciences €17.9 million for charging excessively high prices for a drug used to treat a rare genetic metabolic disorder, marking the first time it has ever imposed a penalty for such an infringement.

19 July 2021

Amazon accused of price gouging during pandemic

A trade union has filed an antitrust complaint against Amazon in the UK alleging that the platform operator abused its dominance by excessively raising the price of essential items during the coronavirus pandemic.

13 July 2021

BT asks UK tribunal to dismiss €469 million damages claim

BT has argued that the UK’s specialist competition tribunal should throw out a proposed class action seeking €469 million in damages on behalf of 2.3 million UK consumers that the telecommunications provider allegedly overcharged for landline services.

24 June 2021

Get unlimited access to all Global Competition Review content